Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

PETQ - PetIQ, Inc.


IEX Last Trade
30.57
0.050   0.164%

Share volume: 300,275
Last Updated: Fri 30 Aug 2024 09:59:54 PM CEST
Drugs and Druggists' Sundries Merchant Wholesalers : -4.55%

PREVIOUS CLOSE
CHG
CHG%

$30.52
0.05
0.16%
This ticker is disabled and data are no longer maintained and up to date.
Fundamental analysis
64%
Profitability 59%
Dept financing 36%
Liquidity 75%
Performance 74%
Company vs Stock growth
vs
Performance
5 Days
0.10%
1 Month
42.29%
3 Months
48.52%
6 Months
66.76%
1 Year
56.51%
2 Year
206.11%
Key data
Stock price
$30.57
P/E Ratio 
68.67
DAY RANGE
N/A - N/A
EPS 
$0.43
52 WEEK RANGE
$15.09 - $30.68
52 WEEK CHANGE
$0.60
MARKET CAP 
905.937 M
YIELD 
N/A
SHARES OUTSTANDING 
29.654 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/05/2024
BETA 
0.65
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$583,254
AVERAGE 30 VOLUME 
$1,642,327
Company detail
CEO: McCord Christensen
Region: US
Website: petiq.com
Employees: 1,890
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Drugs and Druggists' Sundries Merchant Wholesalers
Sector: Wholesale Trade

PetIQ, Inc. operates as a pet medication and wellness company in the United States and internationally. The company offers Rx pet medications, which include flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medications. It operates through approximately 60,000 points of distribution across veterinarian, retail, and e-commerce channels.

Recent news